Could microRNAs Transform Cardiac Diagnosis in Practice?

Exclusive webinar hosted by VPG in collaboration with MI:RNA

Wednesday 1st October 2025 | 7:00 – 8:00pm (BST)

About the Webinar 

VPG, in partnership with MI:RNA, is evaluating a cutting-edge microRNA-based diagnostic for veterinary cardiology.

In this session, you’ll hear from leading experts on how microRNAs could complement existing diagnostics such as NT-proBNP and Troponin I, and what this might mean for decision-making in practice. 

 

What You’ll Learn 

  • Discover why microRNAs react early in cardiac disease
  • Understand how this testing could enable earlier detection and accurate staging in dogs and cats
  • Explore how microRNA diagnostics could integrate seamlessly into your workflow

Who Should Attend? 

  • Veterinary cardiologists 
  • Internal medicine specialists with a cardiology interest 
  • General practitioners managing cardiac cases 

Meet The Speakers

Matt Garland | Laboratory Director, VPG

Matthew Garland is a Laboratory Director at the Veterinary Pathology Group with over 20 years of experience in the veterinary field. A qualified Veterinary Nurse with a background in chemistry and molecular biology, he has contributed to multiple research projects and publications. Matt is passionate about laboratory science, with particular expertise in haematology and quality assurance, and regularly lectures student veterinary nurses as well as presenting CPD at leading UK congresses. He is also committed to developing others through his work with the Royal Society of Biology as a register assessor and awards judge.

Dr Eve Hanks | CEO & Founder, MI:RNA

Dr Eve Hanks is the CEO & Founder of MI:RNA. A veterinary surgeon with over 14 years of experience across production, equine, small animal, and emergency care, she went on to complete a PhD in Immunology at the University of Glasgow. Eve’s clinical pathology work at Scotland’s Rural College inspired her to pioneer the use of microRNAs as novel disease biomarkers, combining them with advanced modelling to bring precision medicine into everyday veterinary practice. As the first spin-out from SRUC, she has grown MI:RNA into a global team of experts dedicated to improving animal health and welfare through innovative diagnostics.

ABOUT MI:RNA

Founded in 2019 by Dr Eve Hanks, MI:RNA is a multi-award winning company focused on the early diagnosis of veterinary disease through the use of a revolutionary biomarker technology and artificial intelligence platform. An entirely new approach to diagnosis that will carve a path to tailored, personalised medicine. Their vision is to reduce disease through cutting edge science and are driven by their goals to help pets live longer, happier lives and to improve the welfare of farmed animals whilst protecting the environment from the impact of agriculture. MI:RNA combines pioneering microRNA biomarker science with AI-powered analysis designed for use in real-world veterinary settings.

Reserve Your Place 

Spaces are limited for this live webinar. Register now to access this exclusive session and influence the future of veterinary cardiology.